Quick Answer
Beta Bionics, Inc. reported Shares Outstanding of 44.36 million shares for fiscal year 2025.
Beta Bionics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 44.36M | +565.3% |
| 2024 | 6.67M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 43.99M | — | +1.2% |
| June 30, 2025 | 43.47M | — | +0.3% |
| March 31, 2025 | 43.35M | — | — |
| December 31, 2024 | 0 | — | — |
- Beta Bionics, Inc. showed an increase of +565.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Beta Bionics, Inc.’s shares outstanding has grown by 565.3% (from 6.67 million shares to 44.36 million shares).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: